Longevity Medical Institute Research eBook

Alzheimer's Disease 1. Study: "Mesenchymal stem cells reduce amyloid-beta and improve cognitive function in Alzheimer's models." o Findings: MSCs reduce amyloid plaques, protect neurons, and improve cognitive function.

o Source: Stem Cell Research & Therapy

Parkinson's Disease 1. Study: "MSCs improve dopaminergic neuron survival and motor function in Parkinson's models." o Findings: MSCs reduce inflammation, enhance neuronal survival, and improve motor symptoms in Parkinson's disease.

Source: PubMed

o

Multiple Sclerosis (MS) 1. Study: "Mesenchymal Stem Cell Therapy in Multiple Sclerosis: A Systematic Review and Meta-Analysis" o Findings: MSC therapy for MS improved motor and sensory functions, helping reduce disability and slow disease progression.

Source: MDPI

o

Stroke Recovery 1. Study: "Mesenchymal stem cell therapy in ischemic stroke: neuroprotective and regenerative effects." o Findings: MSCs reduce inflammation, promote neurogenesis, and improve functional recovery after a stroke.

• Source: Stem Cell Research & Therapy

ALS (Amyotrophic Lateral Sclerosis) 1. Study: "MSC transplantation slows ALS progression and improves motor neuron survival."

o Findings: MSCs reduce neuroinflammation and oxidative stress, slowing disease progression and improving functional outcomes in ALS patients.

© 2024 Longevity Medical Institute. All rights reserved.

24

Made with FlippingBook Annual report maker